DOCSLIB.ORG

The Nore1b/Mst1 Complex Restrains Antigen Receptor-Induced Proliferation of Naïve T Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Nore1b/Mst1 Complex Restrains Antigen Receptor-Induced Proliferation of Naïve T Cells The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells Dawang Zhoua,b, Benjamin D. Medoffc,d, Lanfen Chene, Lequn Lif, Xian-feng Zhanga,b, Maria Praskovaa,b, Matthew Liua,b, Aimee Landryg, Richard S. Blumberge, Vassiliki A. Boussiotisf,h, Ramnik Xavierg,i, and Joseph Avrucha,b,1 aDepartment of Molecular Biology and the bDiabetes, cPulmonary and Critical Care, iGastrointestinal, and hHematology and Oncology Units of the Medical Services, dCenter for Immunology and Inflammatory Diseases, gCenter for Computational and Integrative Biology and fDivision for Surgical Services, Cancer Center of the Massachusetts General Hospital; and eDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02114 Communicated by John T. Potts Jr., Massachusetts General Hospital, Charlestown, MA, October 27, 2008 (received for review May 16, 2008) The Mst1 and Mst2 protein kinases are the mammalian homologs facilitated by the binding of both kinases to the noncatalytic of hippo, a major inhibitor of cell proliferation in Drosophila. Mst1 scaffold protein salvador/shar-pei; hippo also phosphorylates the is most abundant in lymphoid tissues. Mice lacking Mst1 exhibit noncatalytic protein MATS, which then binds to warts/LATS, markedly reduced levels of the Mst1 regulatory protein Nore1B/ promoting its autophosphorylation and activation. Activated RAPL in lymphoid cells, whereas Mst2 abundance is unaltered. warts, in turn, phosphorylates and negatively regulates the Mst1-null mice exhibit normal T cell development but low numbers transcriptional coactivator yorkie. Loss of hippo, warts/LATS, of mature naïve T cells with relatively normal numbers of effector/ Salvador, or MATS each results in overgrowth of a similar memory T cells. In vitro, the Mst1-deficient naïve T cells exhibit nature, whereas yorkie loss-of-function reduces growth and is markedly greater proliferation in response to stimulation of the T epistatic to the other components. Studies in mammalian sys- cell receptor whereas the proliferative responses of the Mst1-null tems indicate that this pathway is largely conserved; LATS1 (18) effector/memory T cell cohort is similar to wild type. Thus, elimi- and MOBKL1A/B (19), the mammalian orthologs of warts/ nation of Mst1 removes a barrier to the activation and proliferative LATS and MATS, are Mst1/2 substrates and negative regulators response of naïve T cells. The levels of Mst1 and Nore1B/RAPL in of cell proliferation (19, 20). Moreover, mice lacking LATS1 wild-type effector/memory T cells are approximately 10% those develop soft tissue sarcomas and ovarian tumors (21). Recipro- seen in wild-type naïve T cells, which may contribute to the cally, YAP, a mammalian homolog of yorkie, is phosphorylated enhanced proliferative responses of the former. Freshly isolated and negatively regulated by LATS1 (22–24). YAP is amplified in Mst1-null T cells exhibit high rates of ongoing apoptosis, a likely a wide variety of murine and human tumors (25); overexpression basis for their low numbers in vivo; they also exhibit defective of YAP transforms mammary epithelial cells in vitro (25) and clustering of LFA-1, as previously observed for Nore1B/RAPL- produces hyperplasia and cancer in mouse liver (22, 26). As deficient T cells. Among known Mst1 substrates, only the phos- regards other outputs, Mst1 activated by oxidant stress phos- phorylation of the cell cycle inhibitory proteins MOBKL1A/B is lost phorylates the Foxo1/3a polypeptides in their forkhead domain, CELL BIOLOGY entirely in TCR-stimulated, Mst1-deficient T cells. Mst1/2-catalyzed disrupting 14–3-3 binding and inhibiting the ability of Akt to MOBKL1A/B phosphorylation slows proliferation and is therefore promote Foxo1/3a nuclear exit (27). a likely contributor to the anti-proliferative action of Mst1 in naïve To define more fully the physiologic roles of Mst1, we gen- T cells. The Nore1B/RAPL-Mst1 complex is a negative regulator of erated mice lacking Mst1 polypeptide expression. naïve T cell proliferation. Results Mst1-Deficient Lymphoid Cells Exhibit Much Lower Nore1B Polypep- Mob1 ͉ Mst1 knockout ͉ RAPL ͉ hippo ͉ Stk4 tide but Unaltered Mst2. Mice lacking Mst1 polypeptide expression were generated from an ES cell line bearing a gene trap inserted st1 and Mst2 are closely related mammalian class II GC between the first and second exons (see supporting information Mprotein (ser/thr) kinases (1) whose overexpression induces (SI) Fig. S1). Mst1-deficient mice survive development, are apoptosis in many transformed cell lines through a combination fertile, and appear unremarkable. Mst1 is expressed at greatest of p53- and Jnk-dependent pathways (2–4). Regarding the abundance in lymphoid organs (Fig. 1A); lymphocytes from the physiological roles of these kinases, Kinashi and colleagues Mst1 trap/trap mice (henceforth called Mst1Ϫ/Ϫ) lack Mst1 demonstrated that the ability of ␣CD3/␣CD28 and chemokines polypeptide but show unaltered levels of Mst2 (Fig. 1B Left). to promote the Rap1-GTP-dependent integrin clustering nec- Mst1 can be coprecipitated with rassf family polypeptides (9); in essary for T cell adhesion and migration (5) is strongly depen- lymphocytes, the Rassf5 isoform Nore1B/RAPL, a Ras-Rap- dent on Mst1 (6), which is proposed to be activated through the binding protein, is a major Mst1 partner (6). Surprisingly, the Rap1-GTP recruitment of a Nore1B (also called RAPL)/Mst1 level of the Nore1B/RAPL polypeptide is greatly diminished in complex to the immunological synapse (7). The Mst1 sub- the Mst1-null lymphocytes (Fig. 1B Left) despite unaltered strate(s) that mediate this response is (are) not known. Mst1 and Mst2 are found in constitutive complexes with members of the Rassf polypeptide family (8, 9), at least two of which, RASSF1A Author contributions: D.Z., B.D.M., L.L., R.S.B., V.A.B., R.X., and J.A. designed research; D.Z., and Nore1A/RASSF5, are well established tumor suppressors B.D.M., L.C., L.L., M.L., A.L., and R.X. performed research; X.Z. and M.P. contributed new reagents/analytic tools; D.Z., B.D.M., L.C., L.L., R.S.B., V.A.B., R.X., and J.A. analyzed data; (10). Nevertheless, direct evidence in support of a tumor sup- and D.Z., B.D.M., R.X., and J.A. wrote the paper. pressor function for Mst1 and/or Mst2 is not yet available. The authors declare no conflict of interest. Mst1 and Mst2 resemble most closely the drosophila protein Freely available online through the PNAS open access option. kinase hippo and human Mst2 can complement hippo deficiency 1To whom correspondence should be addressed at: Department of Molecular Biology, (11). Loss of hippo function results in massive overgrowth of the Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114. E-mail: fly eye, due to an acceleration of cell proliferation together with [email protected]. a deficit in developmental apoptosis (11–14). The pathway This article contains supporting information online at www.pnas.org/cgi/content/full/ downstream of hippo has been extensively described (15–17). 0810773105/DCSupplemental. Hippo phosphorylates the protein kinase warts/LATS, which is © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0810773105 PNAS ͉ December 23, 2008 ͉ vol. 105 ͉ no. 51 ͉ 20321–20326 Downloaded by guest on October 1, 2021 Peripheral blood Spleen A CD4+ A B 25 40 * CD4+/CD62L+ CD4+ * CD4+/ CD8+/ muscle CD8+/ 30 CD8+ CD62L+ CD62L+ CD8+ CD62L+ CD4+/ * CD4+/ * stomach intestine liver lung thymus skin heart * Skel marrow lymph node cortex cerebellum kidney spleen 20 CD44+ CD8+/ CD44+ CD8+/ -Mst1 * CD44+ * 10 * CD44+ -Mst2 0 % total cells % total lymphocytes 6 CD4+ CD4+ l) 14 -Nore1B 3.5 * * CD4+/ / CD4+/CD62L+ 12 3 3 * CD8+ CD62L+ CD8+/ 2.5 CD8+/ 10 * CD8+ CD4+/ * CD62L+ -Mob1 2 CD62L+ 8 * * CD8+/ 6 CD44+ * 1.5 CD4+/ CD8+/ * 4 CD44+ -Actin 1 CD44+ CD44+ 0.5 Total cells X 10 2 0 Total cells (x10 B spleen spleen C +/+ +/- -/- +/+ -/- vector + - - Flag-MST1-WT C 17.45 24.08 11.27 -Mst1 - + - * * Flag-MST1-K59R Mst1 MST1- -28s - - + 3 -Nore1B Nore1B Nore1B- + + + * WT -Mob1 -18s 2 58.25 -Flag 21.33 -Rassf1C 1 CD8 CD44 47.90 12.07 -Mst2 -Nore1B 7.37 -28s Mst1 -Actin -Actin 0 -18s CD4 mRNA (KO/WT) er null liv 32.98 lung colon heart 18.08 Fig. 1. Characterization of Mst1-null mice. (A) Expression of Mst1, Mst2 and intestine stomach CD4 CD62L some other relevant polypeptides in mouse tissues. Mst1/2, Nore1B, and Mob1 expression in mouse organs were analyzed by immunoblot and anti-actin Fig. 2. Peripheral T cell cohorts in wild-type and Mst1-deficient mice. (A)T served as a loading control. (B) Polypeptide and mRNA expression in spleen lymphocytes in the blood of wild-type and Mst1-null mice. The number of ϩ ϩ ϩ ϩ from wild-type and Mst1 gene trap mice. Left, Immunoblot of spleen extracts CD4 , CD8 , and naïve CD4 and CD8 T cells in the peripheral blood of for the polypeptides indicated. Right, Northern blot of splenic RNA. 18S and Mst1-null mice compared with wild-type mice (n ϭ 4 pairs of Mst1-null and 28S ribosomal RNAs serve as internal controls. (C) The Mst1 polypeptide wild-type littermates). Asterisks in this and all subsequent figures indicates a enhances the level of coexpressed Nore1B/RAPL. Vector encoding FLAG- P Ͻ 0.05 or lower calculated from a two-tailed Student t test. Black bars are tagged Nore1B was cotransfected in HEK293 cells with empty vector or vector Mst1ϩ/ϩ and white bars are Mst1Ϫ/Ϫ in this and all later figures. (B) T cell encoding FLAG-Mst1(WT) or FLAG-Mst1(K59R). An immunoblot of the ex- populations in the Mst1-null and wild-type spleen.
Load more

Recommended publications
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • Supplemental Table 1. Complete Gene Lists and GO Terms from Figure 3C
    Supplemental Table 1. Complete gene lists and GO terms from Figure 3C. Path 1 Genes: RP11-34P13.15, RP4-758J18.10, VWA1, CHD5, AZIN2, FOXO6, RP11-403I13.8, ARHGAP30, RGS4, LRRN2, RASSF5, SERTAD4, GJC2, RHOU, REEP1, FOXI3, SH3RF3, COL4A4, ZDHHC23, FGFR3, PPP2R2C, CTD-2031P19.4, RNF182, GRM4, PRR15, DGKI, CHMP4C, CALB1, SPAG1, KLF4, ENG, RET, GDF10, ADAMTS14, SPOCK2, MBL1P, ADAM8, LRP4-AS1, CARNS1, DGAT2, CRYAB, AP000783.1, OPCML, PLEKHG6, GDF3, EMP1, RASSF9, FAM101A, STON2, GREM1, ACTC1, CORO2B, FURIN, WFIKKN1, BAIAP3, TMC5, HS3ST4, ZFHX3, NLRP1, RASD1, CACNG4, EMILIN2, L3MBTL4, KLHL14, HMSD, RP11-849I19.1, SALL3, GADD45B, KANK3, CTC- 526N19.1, ZNF888, MMP9, BMP7, PIK3IP1, MCHR1, SYTL5, CAMK2N1, PINK1, ID3, PTPRU, MANEAL, MCOLN3, LRRC8C, NTNG1, KCNC4, RP11, 430C7.5, C1orf95, ID2-AS1, ID2, GDF7, KCNG3, RGPD8, PSD4, CCDC74B, BMPR2, KAT2B, LINC00693, ZNF654, FILIP1L, SH3TC1, CPEB2, NPFFR2, TRPC3, RP11-752L20.3, FAM198B, TLL1, CDH9, PDZD2, CHSY3, GALNT10, FOXQ1, ATXN1, ID4, COL11A2, CNR1, GTF2IP4, FZD1, PAX5, RP11-35N6.1, UNC5B, NKX1-2, FAM196A, EBF3, PRRG4, LRP4, SYT7, PLBD1, GRASP, ALX1, HIP1R, LPAR6, SLITRK6, C16orf89, RP11-491F9.1, MMP2, B3GNT9, NXPH3, TNRC6C-AS1, LDLRAD4, NOL4, SMAD7, HCN2, PDE4A, KANK2, SAMD1, EXOC3L2, IL11, EMILIN3, KCNB1, DOK5, EEF1A2, A4GALT, ADGRG2, ELF4, ABCD1 Term Count % PValue Genes regulation of pathway-restricted GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, SMAD protein phosphorylation 9 6.34 1.31E-08 ENG pathway-restricted SMAD protein GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, phosphorylation
    [Show full text]
  • Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
    Structure Article Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5 Lisheng Ni,1 Sheng Li,1,4 Jianzhong Yu,3 Jungki Min,1,5 Chad A. Brautigam,2 Diana R. Tomchick,2 Duojia Pan,3 and Xuelian Luo1,* 1Department of Pharmacology 2Department of Biophysics The University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390, USA 3Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA 4Present address: Biologics Department, Shanghai ChemPartner Co. Ltd., Shanghai 201203, China 5Present address: Department of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.str.2013.07.008 SUMMARY dor (Sav1), the NDR family kinases Lats1 and Lats2 (Lats1/2), and the adaptor protein Mob1. They form a central kinase The tumor-suppressive Hippo pathway controls cascade to transduce signals from cell-surface receptors tissue homeostasis through balancing cell prolifera- (Avruch et al., 2012; Hergovich, 2012). tion and apoptosis. Activation of the kinases Mst1 In the canonical Hippo kinase cascade, Mst1/2, in complex and Mst2 (Mst1/2) is a key upstream event in this with Sav1, phosphorylate and activate the Lats1/2-Mob1 com- pathway and remains poorly understood. Mst1/2 plexes, which then phosphorylate the transcriptional coactivator and their critical regulators RASSFs contain Yes-associated protein (YAP), a major downstream target of the Hippo pathway (Dong et al., 2007; Hao et al., 2008; Hong and Salvador/RASSF1A/Hippo (SARAH) domains that Guan, 2012; Huang et al., 2005; Zhao et al., 2007).
    [Show full text]
  • STRIPAK Complexes in Cell Signaling and Cancer
    Oncogene (2016), 1–9 © 2016 Macmillan Publishers Limited All rights reserved 0950-9232/16 www.nature.com/onc REVIEW STRIPAK complexes in cell signaling and cancer Z Shi1,2, S Jiao1 and Z Zhou1,3 Striatin-interacting phosphatase and kinase (STRIPAK) complexes are striatin-centered multicomponent supramolecular structures containing both kinases and phosphatases. STRIPAK complexes are evolutionarily conserved and have critical roles in protein (de) phosphorylation. Recent studies indicate that STRIPAK complexes are emerging mediators and regulators of multiple vital signaling pathways including Hippo, MAPK (mitogen-activated protein kinase), nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are extensively involved in a variety of fundamental biological processes ranging from cell growth, differentiation, proliferation and apoptosis to metabolism, immune regulation and tumorigenesis. Growing evidence correlates dysregulation of STRIPAK complexes with human diseases including cancer. In this review, we summarize the current understanding of the assembly and functions of STRIPAK complexes, with a special focus on cell signaling and cancer. Oncogene advance online publication, 15 February 2016; doi:10.1038/onc.2016.9 INTRODUCTION in the central nervous system and STRN4 is mostly abundant in Recent proteomic studies identified a group of novel multi- the brain and lung, whereas STRN3 is ubiquitously expressed in 5–9 component complexes named striatin (STRN)-interacting phos- almost all tissues. STRNs share a
    [Show full text]
  • The Discovery of a Novel, Ras-Mediated NORE1A/PMLIV Tumor Suppressor Complex." (2016)
    University of Louisville ThinkIR: The University of Louisville's Institutional Repository Electronic Theses and Dissertations 8-2016 The discovery of a novel, Ras-mediated NORE1A/ PMLIV tumor suppressor complex. Jessica Mezzanotte Sharpe University of Louisville Follow this and additional works at: https://ir.library.louisville.edu/etd Part of the Medical Biochemistry Commons, and the Medical Molecular Biology Commons Recommended Citation Sharpe, Jessica Mezzanotte, "The discovery of a novel, Ras-mediated NORE1A/PMLIV tumor suppressor complex." (2016). Electronic Theses and Dissertations. Paper 2539. https://doi.org/10.18297/etd/2539 This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The nivU ersity of Louisville's Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of ThinkIR: The nivU ersity of Louisville's Institutional Repository. This title appears here courtesy of the author, who has retained all other copyrights. For more information, please contact [email protected]. THE DISCOVERY OF A NOVEL, RAS-MEDIATED NORE1A/PMLIV TUMOR SUPPRESSOR COMPLEX By: Jessica Mezzanotte Sharpe B.A., Vanderbilt University, 2010 M.S., University of Louisville, 2014 A Dissertation Submitted to the Faculty of the School of Medicine of the University of Louisville in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biochemistry and Molecular Biology Department of Biochemistry and Molecular Genetics University of Louisville Louisville, KY August, 2016 Copyright 2016 by Jessica Mezzanotte Sharpe All Rights Reserved THE DISCOVERY OF A NOVEL, RAS-MEDIATED NORE1A/PMLIV TUMOR SUPPRESSOR COMPLEX By Jessica Mezzanotte Sharpe B.A., Vanderbilt University, 2010 M.S., University of Louisville, 2014 A Dissertation Approved on June 8, 2016 by the following Dissertation Committee: __________________________________________ Dr.
    [Show full text]
  • Gene Section Short Communication
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Short Communication RASSF5 (Ras association (RalGDS/AF -6) domain family member 5) Lee Schmidt, Geoffrey J Clark University of Louisville, Room 119C, Baxter II Research Building, 580 S Preston Street, Louisville, KY 40202, USA (LS, GJC) Published in Atlas Database: October 2011 Online updated version : http://AtlasGeneticsOncology.org/Genes/RASSF5ID42059ch1q32.html DOI: 10.4267/2042/47279 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2012 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity DNA/RNA Other names: MGC10823, MGC17344, Maxp1, Description NORE1, NORE1A, NORE1B, RAPL, RASSF3 The human gene for RASSF5 is 81 kb in length and is HGNC (Hugo): RASSF5 located on chromosome 1(q32.1). The gene can Location: 1q32.1 produce 4 protein isoforms, two via differential exon usage, a third via differential promoter usage and the genesis of the 4 th (which can be found as an EST clone) is not yet clear. The largest isoform, A, is 418 amino acids long and has a molecular weight of about 47 kD. The protein structure of RASSF5A contains a proline- rich region at the N-terminus which contains potential SH3 binding sites and a nuclear localization signal. This is followed by a cystein rich domain, sometimes Note referred to as a zinc finger. Next is the Ras association Murine RASSF5 originally named Nore1a. Nore1B domain and this is followed by sequence containing the independently identified and designated RAPL. Rat SARAH motif required for binding to the pro-apoptotic RASSF5 also cloned independently and designated kinases MST1 and MST2.
    [Show full text]
  • The Expression of RUNDC3B Is Associated with Promoter Methylation in Lymphoid Malignancies
    The expression of RUNDC3B is associated with promoter methylation in lymphoid malignancies Running Head: Epigenetic regulation of RUNDC3B Keywords: RUNDC3B, DNA methylation, lymphoma, leukemia, B-cell, gene expression Dane W. Burmeister1, Emily H. Smith1,2, Robert T. Cristel1, Stephanie D. McKay1,3, Huidong Shi4, Gerald L. Arthur1, J. Wade Davis5,6, and Kristen H. Taylor1,* 1Department of Pathology and Anatomical Sciences; University of Missouri; Columbia, MO USA; 2Department of Dermatology; University of Michigan Health System; Ann Arbor, MI USA; 3Department of Animal Science; University of Vermont; Burlington, VT USA; 4Department of Biochemistry and Molecular Biology; Georgia Regents University; Augusta, GA USA; 5Department of Health Management and Informatics; University of Missouri; Columbia, MO USA; 6Department of Statistics; University of Missouri, Columbia, MO USA *Corresponding author: Kristen H. Taylor PhD Department of Pathology and Anatomical Sciences One Hospital Drive University of Missouri-Columbia Columbia, Missouri 65212 USA E-mail: [email protected] Telephone: 573-882-5523 FAX: 573-884-4612 This work was supported by a National Institute of Health grant NCI R00 CA132784 (K.H. Taylor) No potential conflicts exist for the authors of this manuscript. Word Count: 2991 This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/HON.2238 1 This article is protected by copyright. All rights reserved. Abstract DNA methylation is an epigenetic modification that plays an important role in regulation of gene expression.
    [Show full text]
  • UC San Diego UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Insights from reconstructing cellular networks in transcription, stress, and cancer Permalink https://escholarship.org/uc/item/6s97497m Authors Ke, Eugene Yunghung Ke, Eugene Yunghung Publication Date 2012 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Insights from Reconstructing Cellular Networks in Transcription, Stress, and Cancer A dissertation submitted in the partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioinformatics and Systems Biology by Eugene Yunghung Ke Committee in charge: Professor Shankar Subramaniam, Chair Professor Inder Verma, Co-Chair Professor Web Cavenee Professor Alexander Hoffmann Professor Bing Ren 2012 The Dissertation of Eugene Yunghung Ke is approved, and it is acceptable in quality and form for the publication on microfilm and electronically ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ Co-Chair ________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION To my parents, Victor and Tai-Lee Ke iv EPIGRAPH [T]here are known knowns; there are things we know we know. We also know there are known unknowns; that is to say we know there
    [Show full text]
  • RASSF6; the Putative Tumor Suppressor of the RASSF Family
    Review RASSF6; the Putative Tumor Suppressor of the RASSF Family Hiroaki Iwasa 1, Xinliang Jiang 2 and Yutaka Hata 1,2,* Received: 2 November 2015; Accepted: 1 December 2015; Published: 9 December 2015 Academic Editor: Reinhard Dammann 1 Department of Medical Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; [email protected] 2 Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-3-5803-5164; Fax: +81-3-5803-0121 Abstract: Humans have 10 genes that belong to the Ras association (RA) domain family (RASSF). Among them, RASSF7 to RASSF10 have the RA domain in the N-terminal region and are called the N-RASSF proteins. In contradistinction to them, RASSF1 to RASSF6 are referred to as the C-RASSF proteins. The C-RASSF proteins have the RA domain in the middle region and the Salvador/RASSF/Hippo domain in the C-terminal region. RASSF6 additionally harbors the PSD-95/Discs large/ZO-1 (PDZ)-binding motif. Expression of RASSF6 is epigenetically suppressed in human cancers and is generally regarded as a tumor suppressor. RASSF6 induces caspase-dependent and -independent apoptosis. RASSF6 interacts with mammalian Ste20-like kinases (homologs of Drosophila Hippo) and cross-talks with the Hippo pathway. RASSF6 binds MDM2 and regulates p53 expression. The interactions with Ras and Modulator of apoptosis 1 (MOAP1) are also suggested by heterologous protein-protein interaction experiments. RASSF6 regulates apoptosis and cell cycle through these protein-protein interactions, and is implicated in the NF-κB and JNK signaling pathways.
    [Show full text]
  • Differences in Gene Expression Profiles and Carcinogenesis Pathways Involved in Cisplatin Resistance of Four Types of Cancer
    596 ONCOLOGY REPORTS 30: 596-614, 2013 Differences in gene expression profiles and carcinogenesis pathways involved in cisplatin resistance of four types of cancer YONG YANG1,2, HUI LI1,2, SHENGCAI HOU1,2, BIN HU1,2, JIE LIU1,3 and JUN WANG1,3 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Capital Medical University, Beijing 100069; 2Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020; 3Department of Physiology, Capital Medical University, Beijing 100069, P.R. China Received December 23, 2012; Accepted March 4, 2013 DOI: 10.3892/or.2013.2514 Abstract. Cisplatin-based chemotherapy is the standard Introduction therapy used for the treatment of several types of cancer. However, its efficacy is largely limited by the acquired drug Cisplatin is primarily effective through DNA damage and is resistance. To date, little is known about the RNA expression widely used for the treatment of several types of cancer, such changes in cisplatin-resistant cancers. Identification of the as testicular, lung and ovarian cancer. However, the ability RNAs related to cisplatin resistance may provide specific of cancer cells to become resistant to cisplatin remains a insight into cancer therapy. In the present study, expression significant impediment to successful chemotherapy. Although profiling of 7 cancer cell lines was performed using oligo- previous studies have identified numerous mechanisms in nucleotide microarray analysis data obtained from the GEO cisplatin resistance, it remains a major problem that severely database. Bioinformatic analyses such as the Gene Ontology limits the usefulness of this chemotherapeutic agent. Therefore, (GO) and KEGG pathway were used to identify genes and it is crucial to examine more elaborate mechanisms of cisplatin pathways specifically associated with cisplatin resistance.
    [Show full text]
  • Genome-Wide Association Study of Growth Performance and Immune Response to Newcastle Disease Virus of Indigenous Chicken in Rwanda
    ORIGINAL RESEARCH published: 16 August 2021 doi: 10.3389/fgene.2021.723980 Genome-Wide Association Study of Growth Performance and Immune Response to Newcastle Disease Virus of Indigenous Chicken in Rwanda Richard Habimana 1,2*, Kiplangat Ngeno 2, Tobias Otieno Okeno 2, Claire D’ andre Hirwa 3, Christian Keambou Tiambo 4 and Nasser Kouadio Yao 5 1 College of Agriculture, Animal Science and Veterinary Medicine, University of Rwanda, Kigali, Rwanda, 2 Animal Breeding and Genomics Group, Department of Animal Science, Egerton University, Egerton, Kenya, 3 Rwanda Agricultural and Animal Resources Development Board, Kigali, Rwanda, 4 Centre for Tropical Livestock Genetics and Health, International Livestock Research Institute, Nairobi, Kenya, 5 Biosciences Eastern and Central Africa – International Livestock Research Institute (BecA-ILRI) Hub, Nairobi, Kenya A chicken genome has several regions with quantitative trait loci (QTLs). However, Edited by: replication and confirmation of QTL effects are required particularly in African chicken Younes Miar, Dalhousie University, populations. This study identified single nucleotide polymorphisms (SNPs) and putative Canada genes responsible for body weight (BW) and antibody response (AbR) to Newcastle Reviewed by: disease (ND) in Rwanda indigenous chicken (IC) using genome-wide association studies Sayed Haidar Abbas, Northwest A & F University, China (GWAS). Multiple testing was corrected using chromosomal false detection rates of 5 and Suxu Tan, 10% for significant and suggestive thresholds, respectively. BioMart data mining and Michigan State University, variant effect predictor tools were used to annotate SNPs and candidate genes, respectively. United States A total of four significant SNPs (rs74098018, rs13792572, rs314702374, and rs14123335) *Correspondence: Richard Habimana significantly (p ≤ 7.6E−5) associated with BW were identified on chromosomes (CHRs) [email protected] 8, 11, and 19.
    [Show full text]
  • The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
    Author Manuscript Published OnlineFirst on August 3, 2016; DOI: 10.1158/0008-5472.CAN-16-0658 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The genomic landscape of pancreatic and periampullary adenocarcinoma Vandana Sandhu1,8, David C Wedge2,11, Inger Marie Bowitz Lothe1,3, Knut Jørgen Labori4, Stefan C Dentro2,11, Trond Buanes4,5, Martina L Skrede1, Astrid M Dalsgaard1, Else Munthe6, Ola Myklebost6, Ole Christian Lingjærde7, Anne-Lise Børresen-Dale1,5, Tone Ikdahl9,10, Peter Van Loo12,13, Silje Nord1, Elin H Kure1,8* 1Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway 2Wellcome Trust Sanger Institute, Hinxton, UK 3Department of Pathology, Oslo University Hospital, Oslo, Norway 4Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway 5Institute of Clinical Medicine, University of Oslo, Oslo, Norway 6Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway 7Department of Computer Science, University of Oslo, Oslo, Norway 8Department for Environmental Health and Science, University college of Southeast Norway, Bø in Telemark, Norway 9Department of Oncology, Oslo University Hospital, Oslo, Norway 10Akershus University Hospital, Nordbyhagen, Norway 11Department of Cancer Genomics, Big Data Institute, University of Oxford, Oxford, UK 12The Francis Crick Institute, London, UK 13Department of Human Genetics, University of Leuven, Leuven, Belgium *Corresponding author: Elin H. Kure, [email protected] Running title: Copy number aberrations in periampullary adenocarcinomas Keywords 1. Pancreatic cancer 2. Copy number aberrations 3. Integrative –omics analysis 4. Driver genes 5. Prognostic subtypes 1 Downloaded from cancerres.aacrjournals.org on September 27, 2021.
    [Show full text]